- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03037528
Examination of Psychological Tools and Tracking in an Online Intervention for Type 2 Diabetes
October 7, 2023 updated by: Laura Saslow, University of Michigan
The goal of the research is to optimize an online and mobile multicomponent 12-month diet and lifestyle intervention for improving the blood glucose control of individuals with type 2 diabetes.
Study Overview
Status
Completed
Conditions
Detailed Description
The core of the program, administered to all participants, includes recommendations to follow a very low carbohydrate, ketogenic diet.
The researchers will test whether adding the following experimental components will enhance the intervention's ability to improve health outcomes: (1) active vs. periodic self-monitoring of dietary intake using an "app"; (2) training vs. no training in positive affect; and (3) training vs. no training in mindfulness and mindful eating.
Study Type
Interventional
Enrollment (Actual)
112
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Michigan
-
Ann Arbor, Michigan, United States, 48109
- University of Michigan
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
21 years to 70 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Weight: Body Mass Index of 25-45 kg/m2 or greater.
- Current HbA1c of 6.5% or higher
- Regular access to the internet
Exclusion Criteria:
- Taking glucose lowering medications other than metformin
- Being pregnant or breastfeeding
- Currently undergoing cancer treatments
- Active use of a weight loss program or medications
- Self-reported impaired renal or hepatic function
- Self-reported untreated thyroid condition
- Vegetarian or vegan
- Weight loss surgery within the past year
- Medical concerns that prevent participants from following the assigned protocol
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Factorial Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Positive Affect, Mindfulness, Tracking
Participants will receive information about positive affect and mindfulness, in addition to being asked to actively track what they eat and receiving the core program
|
Participants will be taught how to follow a very low carbohydrate, ketogenic diet, become more physically active, and get adequate sleep.
Participants will be taught about positive affect skills, such as gratitude, positive reappraisal, and personal strengths.
Participants will be taught about mindfulness and mindful eating techniques.
Participants will be asked to track their diet consistently.
|
Experimental: Mindfulness, Tracking
Participants will receive information about mindfulness, be asked to actively track what they eat, and receive the core program.
|
Participants will be taught how to follow a very low carbohydrate, ketogenic diet, become more physically active, and get adequate sleep.
Participants will be taught about mindfulness and mindful eating techniques.
Participants will be asked to track their diet consistently.
|
Experimental: Positive Affect, Tracking
Participants will receive information about positive affect, be asked to actively track what they eat, and receive the core program.
|
Participants will be taught how to follow a very low carbohydrate, ketogenic diet, become more physically active, and get adequate sleep.
Participants will be taught about positive affect skills, such as gratitude, positive reappraisal, and personal strengths.
Participants will be asked to track their diet consistently.
|
Experimental: Tracking
Participants will be asked to actively track what they eat in addition to receiving the core program.
|
Participants will be taught how to follow a very low carbohydrate, ketogenic diet, become more physically active, and get adequate sleep.
Participants will be asked to track their diet consistently.
|
Experimental: Positive Affect, Mindfulness
Participants will receive information about positive affect and mindfulness in addition to the core program.
|
Participants will be taught how to follow a very low carbohydrate, ketogenic diet, become more physically active, and get adequate sleep.
Participants will be taught about positive affect skills, such as gratitude, positive reappraisal, and personal strengths.
Participants will be taught about mindfulness and mindful eating techniques.
|
Experimental: Positive Affect
Participants will receive information about positive affect in addition to the core program.
|
Participants will be taught how to follow a very low carbohydrate, ketogenic diet, become more physically active, and get adequate sleep.
Participants will be taught about positive affect skills, such as gratitude, positive reappraisal, and personal strengths.
|
Experimental: Mindfulness
Participants will receive information about mindfulness in addition to the core program.
|
Participants will be taught how to follow a very low carbohydrate, ketogenic diet, become more physically active, and get adequate sleep.
Participants will be taught about mindfulness and mindful eating techniques.
|
Experimental: No Extras
Participants will receive the core program.
|
Participants will be taught how to follow a very low carbohydrate, ketogenic diet, become more physically active, and get adequate sleep.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Glycemic Control
Time Frame: 12 months
|
Measured with HbA1c
|
12 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Weight Loss
Time Frame: 12 months
|
Measured with percent change in body weight
|
12 months
|
Depressive Symptoms
Time Frame: 12 months
|
Measured with Patient Health Questionnaire-8.
Eight items, each of which is scored 0 to 3, for a 0 to 24 severity score, with higher being a worse outcome.
|
12 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
January 27, 2017
Primary Completion (Actual)
June 4, 2021
Study Completion (Actual)
June 4, 2021
Study Registration Dates
First Submitted
January 27, 2017
First Submitted That Met QC Criteria
January 27, 2017
First Posted (Estimated)
January 31, 2017
Study Record Updates
Last Update Posted (Actual)
November 7, 2023
Last Update Submitted That Met QC Criteria
October 7, 2023
Last Verified
October 1, 2023
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- HUM00115537
- 5K01DK107456-05 (U.S. NIH Grant/Contract)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Diabetes Mellitus, Type 2
-
SanofiCompletedType 1 Diabetes Mellitus-Type 2 Diabetes MellitusHungary, Russian Federation, Germany, Poland, Japan, United States, Finland
-
Mannkind CorporationTerminatedType 2 Diabetes Mellitus | Type 1 Diabetes MellitusUnited States
-
RWTH Aachen UniversityBoehringer IngelheimCompletedDiabetes Mellitus Type 2 (T2DM)Germany
-
University Hospital Inselspital, BerneCompletedType 2 Diabetes MellitusSwitzerland
-
India Diabetes Research Foundation & Dr. A. Ramachandran...CompletedTYpe 2 Diabetes MellitusIndia
-
Scripps Whittier Diabetes InstituteSan Diego State UniversityCompletedType 2 Diabetes Mellitus (T2DM)United States
-
Griffin HospitalCalifornia Walnut CommissionCompletedDIABETES MELLITUS TYPE 2United States
-
US Department of Veterans AffairsAmerican Diabetes AssociationCompletedType 2 Diabetes MellitusUnited States
-
Dexa Medica GroupCompletedType-2 Diabetes MellitusIndonesia
-
AstraZenecaRecruiting
Clinical Trials on diet and lifestyle program
-
University of MichiganNutrition Science InitiativeCompleted
-
University of MichiganNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)CompletedPolycystic Ovary SyndromeUnited States
-
Universidad de SonoraNot yet recruiting
-
University of MichiganNational Institutes of Health (NIH)CompletedNonalcoholic Fatty Liver DiseaseUnited States
-
VA Office of Research and DevelopmentNot yet recruiting
-
Azienda Ospedaliero-Universitaria CareggiRecruitingDiabetes Mellitus, Type 2Italy
-
UnitedHealth GroupCompletedDiabetes Mellitus, Type 2 | PreDiabetesUnited States
-
Charite University, Berlin, GermanyKarl and Veronica Carstens Foundation; European Association for Ayurveda Therapists...CompletedBurnout-SyndromeGermany
-
University of HelsinkiHelsinki University Central Hospital; University of Western Ontario, Canada; VTT... and other collaboratorsCompletedCardiovascular Diseases | Obesity | Physical ConditioningFinland
-
University of the Basque Country (UPV/EHU)Universidad Pública de Navarra; Ministerio de Economía y Competitividad, SpainCompletedOverweight Children With Type 2 Diabetes RiskSpain